In the days leading up to the meeting, Masimo said RTW more than tripled its ownership to 9.9%, causing its total ownership ...

Masimo delivered Q3 results that mostly aligned with guidance, yet it faces challenges in its non-healthcare segment.

Apple and Masimo's patent and trade secret dispute has intensified through lawsuits as Apple defends its innovations and ...

Apple won the case, though was only awarded a nominal $250, which is the smallest amount it was possible for the court to order. In other words, yes Masimo did in infringe Apple’s patents, but there ...

Masimo (Nasdaq:MASI) shares ticked up before hours today on third-quarter results that came in ahead of the consensus ...

Shares of Masimo Co. (NASDAQ:MASI – Get Free Report) have received an average rating of “Moderate Buy” from the seven ...

Executives said the patient monitoring company’s consumer business will likely become a discontinued operation if it is not ...

The protracted legal wrangling between Apple and health wearable company Masimo has resulted in a nominal win for the tech giant – but failed to achieve its objectives. Apple and Masimo have ...

Note that the Masimo trade secret lawsuit against Apple is separate from both an ITC injunction preventing the sale of Apple Watch models with a blood oxygen sensor and a patent infringement case ...

According to a regulatory filing, following a review by outside counsel, on October 24, 2024, the Board of Directors of Masimo (MASI) adopted ...

Try Now>> See today’s best-performing stocks on TipRanks >> Read More on MASI: Masimo CorpShs NewsMORE Related Stocks Indices Commodities Currencies Stocks ...

The two lawsuits said Masimo copied Apple’s technology while seeking bans on sales and imports of Apple Watches in earlier ...